Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT05024812 · UNKNOWN
Trial details
- NCT number
- NCT05024812
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2023-08-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.